GOLDMAN SACHS GROUP INC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 886982
NEW YORK, NY
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,082,279
+$548,463 QoQ
Shares Held
309,863
+56.0% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Derivatives in ARCT
reported options exposure · as of Jun 30, 2022CallValue
$240,822
CallShares
15,300
PutValue
$240,822
PutShares
15,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ARCT ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ARCT
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,082,279 | 309,863 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,533,816 | 198,681 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,398,220 | 391,227 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,667,336 | 144,728 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,069,543 | 620,257 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,397,849 | 509,712 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,926,279 | 467,076 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,824,862 | 423,303 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,848,922 | 445,541 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,271,004 | 363,370 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,073,630 | 414,641 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $8,827,141 | 345,485 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,833,180 | 377,726 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $7,560,185 | 315,402 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,232,295 | 308,508 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $4,857,921 | 327,795 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,829,103 | 370,337 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $240,822 | 15,300 | Put | Defined | 2024-05-14 | |
| 2022-06-30 | $240,822 | 15,300 | Call | Defined | 2024-05-14 | |
| 2022-03-31 | $7,602,449 | 281,990 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,115,721 | 273,324 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,743,095 | 141,128 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,989,149 | 58,781 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,614,769 | 184,377 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,386,565 | 446,901 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $1,843,650 | 42,500 | Put | Defined | 2021-02-12 | |
| 2020-09-30 | $18,485,738 | 430,903 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,721,297 | 79,617 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $864,242 | 63,594 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||